Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Bio-Technology General grants license to BioLon in Japan

Feb. 26, 1997

Comparative trial of dorzolamide and acetazolamide

Feb. 21, 1997

Alcon describes dihydropyridines for ocular use

Feb. 21, 1997

U.K. launch for P&U glaucoma Rx

Feb. 19, 1997

Gene causing glaucoma located and cloned

Feb. 3, 1997

NYU seeks partner for novel antibacterial technology

Jan. 22, 1997

Olopatadine studied for allergic conjunctivitis

Jan. 20, 1997

Acular approved in U.S. for postoperative ocular inflammation

Jan. 7, 1997

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Jan. 3, 1997

Pilocarpine TDS shows antiglaucoma activity in patients

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.